Literature DB >> 8280815

Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia.

J Mateo1, R Martino, M Borrell, M Garí, F Casas, J Fontcuberta.   

Abstract

An acquired factor VIII inhibitor was found in an 82-year-old woman who presented with numerous spontaneously appearing ecchymoses. Coagulation studies revealed the presence of a prolonged activated partial thromboplastin time that was not corrected by 1:1 mixture with normal fresh plasma after a 2-h incubation. Factor VIII:C was 4%, and the titer for factor VIII inhibitor was 9 Bethesda units. Three months later, after a retroperitoneal hemorrhage, a lymphocytosis was found in her peripheral blood with morphological and surface immunophenotype characteristics of B-cell chronic lymphocytic leukemia, later confirmed by bone marrow morphological and immunocytochemical examinations. To our knowledge, this is the first report of an autoimmune factor VIII inhibitor associated with chronic lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280815     DOI: 10.1007/BF01696353

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  11 in total

Review 1.  Acquired circulating anticoagulants.

Authors:  L A Kunkel
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

2.  Acquired factor VIII inhibitor associated with lung abscess.

Authors:  P S Ganly; J D Isaacs; M A Laffan; C Haslett; J M Hows
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

3.  Factor VIII inhibitor in insulin-dependent diabetes mellitus.

Authors:  T Wajima; G Hall
Journal:  Am J Hematol       Date:  1989-03       Impact factor: 10.047

4.  Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy.

Authors:  R Lottenberg; T B Kentro; C S Kitchens
Journal:  Arch Intern Med       Date:  1987-06

5.  Spontaneously acquired anti-factor VIII antibodies: report of a patient with adenocarcinoma of the prostate.

Authors:  G M Preminger; C L Knupp; J P Hindsley; J M Jenkins; F A Fried; P M Blatt
Journal:  J Urol       Date:  1984-06       Impact factor: 7.450

6.  Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.

Authors:  B D Cheson; J M Bennett; K R Rai; M R Grever; N E Kay; C A Schiffer; M M Oken; M J Keating; D H Boldt; S J Kempin
Journal:  Am J Hematol       Date:  1988-11       Impact factor: 10.047

7.  Hairy cell leukemia and factor VIII inhibitor: a case report.

Authors:  A Komminoth; P Dufour; J P Bergerat; M L Wiesel; A Falkenrodt; F Oberling
Journal:  Nouv Rev Fr Hematol       Date:  1992

8.  Acquired factor VIII inhibitor in a patient with mycosis fungoides.

Authors:  C C Waddell; D E Lehane; M A Zubler
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

9.  A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.

Authors:  D Green; K Lechner
Journal:  Thromb Haemost       Date:  1981-06-30       Impact factor: 5.249

10.  In vitro detection of mild inhibitors to factor VIII in hemophilia.

Authors:  N P Ewing; C K Kasper
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

View more
  2 in total

Review 1.  Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review.

Authors:  Koji Yamamoto; Junki Takamatsu; Hidehiko Saito
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

2.  Spontaneous retroperitoneal hemorrhage in a patient with prolymphocytic transformation of chronic lymphocytic leukemia.

Authors:  Gwynivere A Davies; Alejandro Lazo-Langner; Michael Shkrum; Leonard Minuk
Journal:  Case Rep Hematol       Date:  2013-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.